Hu, Y., Yang, J., Chen, J., Li, K. (2026). Neoadjuvant camrelizumab with chemotherapy (NACI) in PD-L1-negative locally advanced cervical cancer: An open-label, multi-center, single-arm, phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17510